AML, Adult Recurrent Clinical Trials

7 clinical trials for AML, Adult Recurrent across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation — RECRUITING · PHASE1
• BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS — RECRUITING · PHASE1
• Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML — RECRUITING · PHASE1
• A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS) — COMPLETED · PHASE1
• Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS — COMPLETED · PHASE1
• A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients — OTHER · PHASE1
• Flotetuzumab Expanded Access Program — TERMINATED

Refine this search